person · Reporting owner
Lourenco Leticia Goncalves
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EMERSON ELECTRIC COEMR · Entity 2942 | Director | February 04, 2025 | February 06, 2025 |
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | President, Health & Bioscience | April 01, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EMERSON ELECTRIC CO
Report date February 04, 2025 · Filed February 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,762 |
Reported balance
After 2025-02-04 transaction · row 1
1 source rowRow 1 · 2025-02-04 · Grant · Acquired 1,476 · Balance 4,762 F1: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2: Price is not applicable to acquisitions resulting from grants of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).
F2: Price is not applicable to acquisitions resulting from grants of restricted stock units.
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,075 |
Ending reported balance
After 2026-04-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-04-01 · Exercise / conversion · Acquired 4,305 · Balance 4,305 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Row 2 · 2026-04-01 · Exercise / conversion · Acquired 3,013 · Balance 7,318 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Row 3 · 2026-04-01 · Tax withholding · Disposed 1,335 · Balance 5,983 F2: Reflects shares withheld for taxes payable upon the vesting of RSUs. Row 4 · 2026-04-01 · Tax withholding · Disposed 1,908 · Balance 4,075 F2: Reflects shares withheld for taxes payable upon the vesting of RSUs. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,735 |
Reported balance
After 2026-04-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-01 · Grant · Acquired 13,780 · Balance 35,735 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F3: RSUs vest in three equal tranches with respect to the shares of Common Stock on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to continued employment with IFF. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 32,722 |
Reported balance
After 2026-04-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-01 · Exercise / conversion · Disposed 3,013 · Balance 32,722 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F4: RSUs vested on April 1, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 28,417 |
Reported balance
After 2026-04-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-01 · Exercise / conversion · Disposed 4,305 · Balance 28,417 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F4: RSUs vested on April 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.
F2: Reflects shares withheld for taxes payable upon the vesting of RSUs.
F3: RSUs vest in three equal tranches with respect to the shares of Common Stock on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to continued employment with IFF.
F4: RSUs vested on April 1, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 4,305 | $72.57 | $312,413.85 |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · derivative · entry 7 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,417 Underlying: Common Stock · 4,305 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: RSUs vested on April 1, 2026. F4 · derivative.expiration_date: RSUs vested on April 1, 2026. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 3,013 | $72.57 | $218,653.41 |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · derivative · entry 6 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,722 Underlying: Common Stock · 3,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: RSUs vested on April 1, 2026. F4 · derivative.expiration_date: RSUs vested on April 1, 2026. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 13,780 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · derivative · entry 5 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,735 Underlying: Common Stock · 13,780 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F3 · derivative.exercise_date: RSUs vest in three equal tranches with respect to the shares of Common Stock on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to continued employment with IFF. F3 · derivative.expiration_date: RSUs vest in three equal tranches with respect to the shares of Common Stock on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to continued employment with IFF. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 1,908 | $72.57 | $138,463.56 |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · nonDerivative · entry 4 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,075 F2 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 1,335 | $72.57 | $96,880.95 |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · nonDerivative · entry 3 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,983 F2 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 3,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · nonDerivative · entry 2 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:13 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 4,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004370 · doc4.xml · nonDerivative · entry 1 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 23:55 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 21,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003961 · doc4.xml · derivative · entry 1 Lourenco Leticia Goncalves · CIK 0001974509 · President, Health & Bioscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,955 Underlying: Common Stock · 21,955 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 21,955 shares of Common Stock on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 21,955 shares of Common Stock on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to continued employment with IFF. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:17 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000032604-25-000022 · wk-form4_1738876617.xml · nonDerivative · entry 1 Lourenco Leticia Goncalves · CIK 0001974509 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,762 F1 · kind: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,476 restricted stock units having a fair market value of $128.6800 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:55 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-002573 · form4.xml · nonDerivative · entry 1 Lourenco Leticia Goncalves · CIK 0001974509 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,286 F1 · kind: Grant to Reporting Person of 1,867 restricted stock units having a fair market value of $93.7050 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,867 restricted stock units having a fair market value of $93.7050 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:39 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-010111 · form4.xml · nonDerivative · entry 1 Lourenco Leticia Goncalves · CIK 0001974509 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,419 F1 · kind: Grant to Reporting Person of 1,419 restricted stock units having a fair market value of $82.1750 per unit on the date of the grant under shareholder approved benefit plan pursuant to Rule 16b-3(d) in connection with annual retainer paid to all non-management directors. F1 · shares: Grant to Reporting Person of 1,419 restricted stock units having a fair market value of $82.1750 per unit on the date of the grant under shareholder approved benefit plan pursuant to Rule 16b-3(d) in connection with annual retainer paid to all non-management directors. F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.